EDGAR Filing Documents for 0001564590-21-000163

Form 8-K - Current report:

SEC Accession No. 0001564590-21-000163

Filing Date

2021-01-04

Accepted

2021-01-04 16:11:41

Documents

Period of Report

2020-12-31

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	arav-8k_20201231.htm	8-K	34730
2	EX-10.1	arav-ex101_27.htm	EX-10.1	298024
3	EX-99.1	arav-ex991_77.htm	EX-99.1	11821
4	GRAPHIC	gyxjxus0cg2x000001.jpg	GRAPHIC	2000
	Complete submission text file	0001564590-21-000163.txt		348847

Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098

Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910

Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 21501897
SIC: 2834 Pharmaceutical Preparations